SQZ Biotechnologies (SQZ) Competitors $0.03 0.00 (0.00%) As of 07/3/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsTrendsBuy This Stock SQZ vs. CISS, GVH, USDP, MOND, AIRTP, ATCOL, BLDEW, RA, ESEA, and HSHPShould you be buying SQZ Biotechnologies stock or one of its competitors? The main competitors of SQZ Biotechnologies include C3is (CISS), Globavend (GVH), USD Partners (USDP), Mondee (MOND), Air T (AIRTP), Atlas (ATCOL), Blade Air Mobility (BLDEW), Brookfield Real Assets Income Fund (RA), Euroseas (ESEA), and Himalaya Shipping (HSHP). These companies are all part of the "transportation" industry. SQZ Biotechnologies vs. Its Competitors C3is Globavend USD Partners Mondee Air T Atlas Blade Air Mobility Brookfield Real Assets Income Fund Euroseas Himalaya Shipping SQZ Biotechnologies (NYSE:SQZ) and C3is (NASDAQ:CISS) are both small-cap transportation companies, but which is the better business? We will compare the two companies based on the strength of their dividends, valuation, earnings, analyst recommendations, media sentiment, profitability, institutional ownership and risk. Do insiders and institutionals have more ownership in SQZ or CISS? 38.5% of SQZ Biotechnologies shares are held by institutional investors. Comparatively, 10.5% of C3is shares are held by institutional investors. 16.0% of SQZ Biotechnologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has more volatility & risk, SQZ or CISS? SQZ Biotechnologies has a beta of 2.34, meaning that its share price is 134% more volatile than the S&P 500. Comparatively, C3is has a beta of 1.66, meaning that its share price is 66% more volatile than the S&P 500. Is SQZ or CISS more profitable? C3is has a net margin of 3.62% compared to SQZ Biotechnologies' net margin of -369.96%. C3is' return on equity of 7.94% beat SQZ Biotechnologies' return on equity.Company Net Margins Return on Equity Return on Assets SQZ Biotechnologies-369.96% -119.83% -59.90% C3is 3.62%7.94%5.19% Does the media refer more to SQZ or CISS? In the previous week, SQZ Biotechnologies' average media sentiment score of 0.00 equaled C3is'average media sentiment score. Company Overall Sentiment SQZ Biotechnologies Neutral C3is Neutral Which has preferable earnings and valuation, SQZ or CISS? C3is has higher revenue and earnings than SQZ Biotechnologies. C3is is trading at a lower price-to-earnings ratio than SQZ Biotechnologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSQZ Biotechnologies$18.16M0.05-$79.46M-$2.61-0.01C3is$42.30M0.06-$2.75M-$51.85-0.06 SummaryC3is beats SQZ Biotechnologies on 6 of the 11 factors compared between the two stocks. Get SQZ Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SQZ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SQZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SQZ vs. The Competition Export to ExcelMetricSQZ BiotechnologiesBiological Products IndustryMedical SectorNYSE ExchangeMarket Cap$826K$202.66M$5.49B$20.63BDividend YieldN/AN/A5.38%3.75%P/E Ratio-0.01N/A27.4728.08Price / Sales0.05223.65408.8654.17Price / CashN/A22.4436.6322.31Price / Book0.015.618.094.59Net Income-$79.46M-$96.61M$3.17B$985.44M7 Day PerformanceN/A-0.65%2.81%2.78%1 Month PerformanceN/A-1.00%3.67%5.41%1 Year PerformanceN/A16.17%35.41%14.61% SQZ Biotechnologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SQZSQZ BiotechnologiesN/A$0.03flatN/A-24.3%$826K$18.16M-0.011,620CISSC3is0.3941 of 5 stars$3.28+1.9%N/A-83.6%$2.28M$42.30M-0.06N/APositive NewsGap UpGVHGlobavendN/A$0.12-13.2%N/A-92.5%$1.99M$16.54M0.007Gap DownHigh Trading VolumeUSDPUSD Partners0.0862 of 5 stars$0.01-15.6%N/A-84.8%$260K$72.32M-0.0190Gap UpHigh Trading VolumeMONDMondeeN/AN/A$3.63+∞N/A$87K$232.97M0.001,226AIRTPAir TN/A$17.12+0.2%N/A+0.8%$0.00$298.22M0.00500ATCOLAtlasN/A$25.30+0.0%N/A+1.7%$0.00N/A0.006,200BLDEWBlade Air MobilityN/A$0.21-2.6%N/A+32.6%$0.00$251.49M0.00130Gap DownRABrookfield Real Assets Income FundN/A$13.37+0.5%N/A+4.8%$0.00$67.52M-121.55N/ADividend AnnouncementESEAEuroseas4.8201 of 5 stars$44.72-1.8%$61.00+36.4%+17.5%$0.00$212.90M2.41360Dividend AnnouncementHSHPHimalaya Shipping0.3734 of 5 stars$5.79-3.3%N/A-31.1%$0.00$123.58M20.682Gap Up Related Companies and Tools Related Companies CISS Competitors GVH Competitors USDP Competitors MOND Competitors AIRTP Competitors ATCOL Competitors BLDEW Competitors RA Competitors ESEA Competitors HSHP Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:SQZ) was last updated on 7/4/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredHave you heard of “E.I.”?Inside Expert: New "E.I." Tech Could Be Poised For 200,000% Growth Meta, Apple, and even NASA are rushing t...Behind the Markets | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SQZ Biotechnologies Please log in to your account or sign up in order to add this asset to your watchlist. Share SQZ Biotechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
